Adial Pharmaceuticals, Inc. (ADIL)

3.92 -0.30 (-7.11%) USD  |  NASDAQ  |  Oct 23, 16:00
4.05 +0.13 (+3.32%) After-Hours: 20:00
More

Adial Pharmaceuticals EPS Diluted (Quarterly) : -11.25 for June 30, 2026

EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2016. Start Trial.
Date Value
June 30, 2026 -11.25
March 31, 2026 -1.476
December 31, 2025 -1.797
September 30, 2025 -2.022
June 30, 2025 -4.609
March 31, 2025 -0.3408
December 31, 2024 -7.996
September 30, 2024 -0.3756
June 30, 2024 -0.5877
March 31, 2024 -2.192
December 31, 2023 -1.154
September 30, 2023 -1.144
June 30, 2023 -1.392
March 31, 2023 -52.90
December 31, 2022 -1678.41
September 30, 2022 -1888.61
June 30, 2022 -98.89
March 31, 2022 -3.14
December 31, 2021 -7.101
September 30, 2021 -5.438
June 30, 2021 -6.312
Date Value
March 31, 2021 -7.594
December 31, 2020 -6.026
September 30, 2020 -6.111
June 30, 2020 -4.010
March 31, 2020 -5.422
December 31, 2019 -4.964
September 30, 2019 -4.184
June 30, 2019 -5.219
March 31, 2019 -8.128
December 31, 2018 -4.624
September 30, 2018 -36.92
June 30, 2018 -6.834
March 31, 2018 -1.393
December 31, 2017 -1.486
September 30, 2017 -1.076
June 30, 2017 -0.9718
March 31, 2017 -0.6565
December 31, 2016 -0.3512
September 30, 2016 -0.3802
June 30, 2016 -0.3518
March 31, 2016 -0.4618

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. 1.052
Corcept Therapeutics, Inc. 0.356
Veru, Inc. -0.3032
Johnson & Johnson 0.0858
Eli Lilly & Co. 7.939

EPS Diluted (Quarterly) Related Metrics

Net Income (Quarterly) -51.99M
Total Expenses (Quarterly) 51.99M
Enterprise Value 43.93M
Earnings Yield -422.0%
Normalized Earnings Yield -252.20